Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
The pharmacogenomics of Alzheimer's disease
Victor Crentsil
Research output
:
Contribution to journal
›
Review article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The pharmacogenomics of Alzheimer's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Pharmacogenomics
100%
Alzheimer's Disease Treatment
33%
Therapeutic Agents
16%
Non-family
16%
Age-related Illnesses
16%
Patient's Family
16%
Disease-modifying Therapy
16%
Neurodegenerative Diseases
16%
Alzheimer's Disease Pathology
16%
Apolipoprotein E
16%
Geriatric Patients
16%
Drug Target
16%
Sporadic Alzheimer's Disease
16%
Emotional Impact
16%
Economic Impact
16%
Familial Alzheimer's Disease
16%
Time Change
16%
Medicine and Dentistry
Alzheimer's Disease
100%
Pharmacogenomics
100%
Allele
10%
Therapeutic Agent
10%
Disease Modifying Therapy
10%
Geriatrics
10%
Apolipoprotein E
10%
Neurodegenerative Disorder
10%
Familial Alzheimer's Disease
10%
Geriatric Syndrome
10%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Pharmacogenomics
100%
Disease
18%
Syndrome
9%
Apolipoprotein E
9%
Biochemistry, Genetics and Molecular Biology
Pharmacogenomics
100%
Genetics
66%
Allele
33%
Apolipoprotein E
33%
Immunology and Microbiology
Pharmacogenomics
100%
Allele
33%
Neuroscience
Alzheimer's Disease
100%
Neurodegenerative Disorder
10%
Apolipoprotein E
10%
Familial Alzheimer's Disease
10%